Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/15/21 → 7/31/24 |
Funding
- Genmab US Incorporated: $48,762.00
A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator s Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Iragavarapu, Chaitanya (PI)
- Hildebrandt, Gerhard (Former PI)